Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- PDLI +21.9%, FNKO +13.2%, CCXI +9.6%, SPKE +9.3%, (also announces two acquisitions and retains Morgan Stanley as financial advisor to explore strategic alternatives), UNFI +8.3%, UPLD +7.6%, LOCO +7.3%, KMG +5.5%, FLXN +3.7%,PAGS +2.4%, CRSP +1.5%, PIRS +1.4%, CHRS +1.1%, REGI +0.9%
M&A news:
- DAN +1% (Dana Inc to combine with the Driveline division of GKN)
Other news:
- ACRX +15.8% (announces receipt of Type A FDA meeting minutes and plans to resubmit the DSUVIA New Drug Application in Q2 2018; reported earnings)
- TXMD +13.4% (announced FDA acceptance of NDA and PDUFA date for TX-001HR of October 28, 2018 )
- DPW +11.6% (DPW Holdings subsidiary Super Crypto Mining to purchase another 1,100 S9 mining machines)
- DTEA +8.2% (DAVIDsTEA co-founder Herschel Segal steps down from Board; he (Rainy Day Investments) decided to begin the process of exploring leading a privatization transaction for DTEA; Board considering options; COO also reigns from Board)
- MYOK +3.4% (announces positive results from low-dose cohort of Phase 2 PIONEER-HCM study of Mavacamten in symptomatic, obstructive hypertrophic cardiomyopathy patients; also reports earnings)
- WYNN +2.5% (Wynn Resorts, Universal Entertainment and Aruze USA reach settlement agreement )
- ENT +1.3% (announced $150 mln investment from Searchlight Capital Partners, appointed Jeff Leddy as Executive Chairman and Josh Marks as CEO)
- GNC +1.2% (GNC Holdings and Guardian Healthcare announced 'major' expansion of presence in India - expected to increase to over 4,000 retail outlets across India by 2020)
- WEN +1.1% (CFO disclosed the purchase of 5K shares)
Analyst comments:
- CORT +4.9% (initiated with a Buy at B. Riley FBR)
- CYBR +2.4% (upgraded to Buy at BofA/Merrill)
- WMB +1.2% (upgraded to Overweight at JP Morgan)
- BURL +0.9% (initiated with a Buy at Loop Capital)